Issue 7, 2019

Discovery of novel amide tripeptides as pancreatic lipase inhibitors by virtual screening

Abstract

Pancreatic lipase (PL) is a key enzyme for the degradation of triglycerides absorbed in the diet and it is involved in several pathologies, such as acute pancreatitis, an inflammatory state of the pancreas. In this work we performed the virtual screening of a tripeptide library, with the aim to discover novel lead compounds as inhibitors of human PL. The 9 top-ranked peptides were synthesized by solid phase peptide synthesis and tested in vitro. Among them, peptides M5 and M7 were found to be the most potent inhibitors of the series, validating our method as a useful strategy to discover peptide inhibitors.

Graphical abstract: Discovery of novel amide tripeptides as pancreatic lipase inhibitors by virtual screening

Article information

Article type
Paper
Submitted
20 Nov 2018
Accepted
22 Jan 2019
First published
22 Jan 2019

New J. Chem., 2019,43, 3208-3217

Discovery of novel amide tripeptides as pancreatic lipase inhibitors by virtual screening

A. Stefanucci, M. P. Dimmito, G. Zengin, G. Luisi, S. Mirzaie, E. Novellino and A. Mollica, New J. Chem., 2019, 43, 3208 DOI: 10.1039/C8NJ05884A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements